AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Acerus to Report First Quarter 2019 Financial Results and Host Investor Call

May 6, 2019

TORONTO--(BUSINESS WIRE)--May 6, 2019--Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its first quarter 2019 financial and operating results on Monday May 13, 2019 before the market opens. The company will host a conference call on Monday, May 13, 2019 at 8:30 a.m. Eastern Time.

To access the call live, please dial 647-484-0475 or 1-888-882-4478. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference call will be available until 11:59 p.m. Eastern Time on Tuesday, May 21, 2019 by dialing 905-694-9451 or 1-800-408-3053, using access code: 7327615#.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve patient experience, with a primary focus in the field of men’s and women’s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.

Acerus’ shares trade on TSX under the symbol ASP. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190506005065/en/

CONTACT: Robert Motz

Chief Financial Officer

rmotz@aceruspharma.com

(905) 817-8288

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Acerus Pharmaceuticals Corporation

Copyright Business Wire 2019.

PUB: 05/06/2019 07:00 AM/DISC: 05/06/2019 07:01 AM

http://www.businesswire.com/news/home/20190506005065/en